25253696|t|Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein.
25253696|a|Pathogenic mutations in the amyloid precursor protein (APP) gene have been described as causing early onset familial Alzheimer disease (AD). We recently identified a rare APP variant encoding an alanine-to-threonine substitution at residue 673 (A673T) that confers protection against development of AD (Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., Hoyte, K., Gustafson, A., Liu, Y., Lu, Y., Bhangale, T., Graham, R. R., Huttenlocher, J., Bjornsdottir, G., Andreassen, O. A., Jonsson, E. G., Palotie, A., Behrens, T. W., Magnusson, O. T., Kong, A., Thorsteinsdottir, U., Watts, R. J., and Stefansson, K. (2012) Nature 488, 96-99). The Ala-673 residue lies within the beta-secretase recognition sequence and is part of the amyloid-beta (Abeta) peptide cleavage product (position 2 of Abeta). We previously demonstrated that the A673T substitution makes APP a less favorable substrate for cleavage by BACE1. In follow-up studies, we confirm that A673T APP shows reduced cleavage by BACE1 in transfected mouse primary neurons and in isogenic human induced pluripotent stem cell-derived neurons. Using a biochemical approach, we show that the A673T substitution modulates the catalytic turnover rate (V(max)) of APP by the BACE1 enzyme, without affecting the affinity (K(m)) of the APP substrate for BACE1. We also show a reduced level of Abeta(1-42) aggregation with A2T Abeta peptides, an observation not conserved in Abeta(1-40) peptides. When combined in a ratio of 1:9 Abeta(1-42)/Abeta(1-40) to mimic physiologically relevant mixtures, A2T retains a trend toward slowed aggregation kinetics. Microglial uptake of the mutant Abeta(1-42) peptides correlated with their aggregation level. Cytotoxicity of the mutant Abeta peptides was not dramatically altered. Taken together, our findings demonstrate that A673T, a protective allele of APP, reproducibly reduces amyloidogenic processing of APP and also mildly decreases Abeta aggregation. These effects could together have an additive or even synergistic impact on the risk of developing AD.
25253696	24	41	Alzheimer disease	Disease	MESH:D000544
25253696	60	65	A673T	ProteinMutation	tmVar:p|SUB|A|673|T;HGVS:p.A673T;VariantGroup:0;CorrespondingGene:351;RS#:63750847;CorrespondingSpecies:9606;CA#:130092
25253696	76	101	amyloid precursor protein	Gene	11820
25253696	131	156	amyloid precursor protein	Gene	351
25253696	220	237	Alzheimer disease	Disease	MESH:D000544
25253696	239	241	AD	Disease	MESH:D000544
25253696	298	346	alanine-to-threonine substitution at residue 673	ProteinMutation	tmVar:p|SUB|A|673|T;HGVS:p.A673T;VariantGroup:0;CorrespondingGene:351;RS#:63750847;CorrespondingSpecies:9606;CA#:130092
25253696	348	353	A673T	ProteinMutation	tmVar:p|SUB|A|673|T;HGVS:p.A673T;VariantGroup:0;CorrespondingGene:351;RS#:63750847;CorrespondingSpecies:9606;CA#:130092
25253696	402	404	AD	Disease	MESH:D000544
25253696	923	935	amyloid-beta	Gene	351
25253696	937	942	Abeta	Gene	351
25253696	984	989	Abeta	Gene	351
25253696	1028	1033	A673T	ProteinMutation	tmVar:p|SUB|A|673|T;HGVS:p.A673T;VariantGroup:0;CorrespondingGene:351;RS#:63750847;CorrespondingSpecies:9606;CA#:130092
25253696	1100	1105	BACE1	Gene	23821
25253696	1145	1150	A673T	ProteinMutation	tmVar:p|SUB|A|673|T;HGVS:p.A673T;VariantGroup:0;CorrespondingGene:351;RS#:63750847;CorrespondingSpecies:9606;CA#:130092
25253696	1181	1186	BACE1	Gene	23821
25253696	1202	1207	mouse	Species	10090
25253696	1240	1245	human	Species	9606
25253696	1340	1345	A673T	ProteinMutation	tmVar:p|SUB|A|673|T;HGVS:p.A673T;VariantGroup:0;CorrespondingGene:351;RS#:63750847;CorrespondingSpecies:9606;CA#:130092
25253696	1420	1425	BACE1	Gene	23821
25253696	1497	1502	BACE1	Gene	23821
25253696	1565	1568	A2T	DNAMutation	tmVar:c|SUB|A|2|T;HGVS:c.2A>T;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
25253696	1569	1574	Abeta	Gene	351
25253696	1739	1742	A2T	DNAMutation	tmVar:c|SUB|A|2|T;HGVS:c.2A>T;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
25253696	1889	1901	Cytotoxicity	Disease	MESH:D064420
25253696	1916	1921	Abeta	Gene	351
25253696	2007	2012	A673T	ProteinMutation	tmVar:p|SUB|A|673|T;HGVS:p.A673T;VariantGroup:0;CorrespondingGene:351;RS#:63750847;CorrespondingSpecies:9606;CA#:130092
25253696	2121	2126	Abeta	Gene	351
25253696	2239	2241	AD	Disease	MESH:D000544
25253696	Negative_Correlation	MESH:D000544	RS#:63750847;HGVS:p.A673T;CorrespondingGene:351
25253696	Association	MESH:D000544	11820
25253696	Association	MESH:D000544	351
25253696	Association	11820	351
25253696	Association	MESH:D000544	351

